GlassScriptPhysician profile
Jonathan Torrens Olan
NPI 1831682061
$9,560.06
in general payments reported to CMS, 2019-2025
31 companies · $2,930 in 2025
The $2,930 reported for 2025 was more than what 82% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $62.27 · 2021: $748 · 2022: $1,495 · 2023: $1,856 · 2024: $2,469 · 2025: $2,930.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,430 · Travel and Lodging: $1,396 · Education: $428.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,430.25 |
| Travel and Lodging | $1,396.49 |
| Education | $428.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,940.46 | 2021-2025 | Fasenra, Tezspire, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,190.45 | 2020-2025 | Ofev, Jascayd |
| Olympus Corporation of The Americas | $922.97 | 2025 | Spiration Valve System |
| Glaxosmithkline, LLC. | $664.29 | 2021-2025 | Arexvy, Nucala, Trelegy Ellipta |
| Intuitive Surgical, INC. | $548.01 | 2025 | |
| Genzyme Corporation | $502.41 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $497.85 | 2021-2025 | Xarelto, Uptravi, Opsumit |
| United Therapeutics Corporation | $408.22 | 2023-2025 | Tyvaso, Tyvaso, Steen Solution |
| E.R. Squibb & Sons, L.L.C. | $400.72 | 2021-2024 | Opdivo, Eliquis |
| Bayer Healthcare Pharmaceuticals INC. | $391.46 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $254.55 | 2022-2025 | Winrevair, Capvaxive, Verquvo |
| Sanofi-Aventis U.S. LLC | $244.25 | 2021-2025 | |
| Jazz Pharmaceuticals INC. | $203.30 | 2024-2025 | |
| Actelion Pharmaceuticals US, INC. | $197.96 | 2022-2025 | Opsumit, Uptravi |
| Takeda Pharmaceuticals U.S.A., INC. | $188.97 | 2022-2025 | Glassia |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Caris Mpi, INC. | $145.00 | 2025 | Mi Cancer Seek |
| Pbg Puerto Rico LLC | $108.76 | 2021-2025 | |
| Lilly USA, LLC | $101.51 | 2025 | Zepbound |
| Olympus Latin America, INC. | $80.48 | 2022 | |
| Amgen INC. | $79.76 | 2024 | Tezspire |
| Mylan Specialty L.P. | $76.34 | 2024 | Yupelri |
| Genentech, INC. | $76.14 | 2023 | Xofluza, Esbriet, Actemra |
| Eli Lilly Export S.A. Puerto Rico Branch | $72.92 | 2025 | Zepbound |
| Pfizer INC. | $51.58 | 2023 | |
| Abbvie INC. | $42.69 | 2021 | |
| Insmed, INC. | $39.86 | 2024 | Arikayce |
| Mallinckrodt Hospital Products INC. | $37.50 | 2023 | Acthar |
| Mylan LLC | $27.51 | 2021 | |
| Ani Pharmaceuticals, INC. | $25.00 | 2023 | Purified Cortrophin Gel |
| Harmony Biosciences LLC | $23.85 | 2025 | |
| Medicure Pharma INC. | $15.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Torrens Olan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.